These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6245002)

  • 21. Immunoglobulin a as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population.
    Herremans T; Kimman TG; Conyn-Van Spaendonck MA; Buisman A; de Melker H; Abbink F; Bijkerk P; Koopmans MP
    Clin Infect Dis; 2002 Apr; 34(8):1067-75. PubMed ID: 11914995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary results on the use of human diploid fibroblasts for inactivated polio virus vaccine production.
    Larsson B; Litwin J
    Dev Biol Stand; 1980; 46():241-7. PubMed ID: 6245000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polio antibody outfit of newborns and infants born after 20 years of mass vaccination with live poliovaccine.
    Koza J; Matyásová I; Danes L; Skovránek V; Havelková M
    J Hyg Epidemiol Microbiol Immunol; 1984; 28(1):25-32. PubMed ID: 6325534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of single-radial-diffusion and autoradiographic zone size enhancement (ZE) techniques for poliovirus antigens.
    Schild GC; Wood JM; Minor PD; Dandawate CN; Magrath DI
    Dev Biol Stand; 1981; 47():77-85. PubMed ID: 6262163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Properties of poliovirus detected in waste waters in the administration of nonhomogeneous vaccine (author's transl)].
    Matyásová I; Koza J
    Cesk Epidemiol Mikrobiol Imunol; 1981 Jan; 30(1):49-55. PubMed ID: 6258812
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on new attenuated strains of type I live poliovirus vaccine. II. Investigation on a series of field trials with "Zhong I9" strain].
    Chen TQ; Li CZ; Ni SF; Shi M; Luo GX; Dong DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):373-7. PubMed ID: 6327097
    [No Abstract]   [Full Text] [Related]  

  • 27. Antigenic potency of inactivated poliovirus vaccines.
    Moynihan M; Petersen I
    Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Removal of poliovirus type 1 from a protein mixture using an immunoaffinity chromatography column.
    Cameron-Smith R; Harbour C
    Biomed Chromatogr; 2001 Nov; 15(7):471-83. PubMed ID: 11746244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of poliovirus obtained from human diploid cells by means of DEAE-Sepharose.
    Horodniceanu F; Panon G; Le Fur R; Barme M
    Dev Biol Stand; 1979; 42():75-80. PubMed ID: 223925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence and quantification of cell substrate DNA in inactivated poliovirus vaccine.
    Crainic R; Horodniceanu F; Barme M
    Dev Biol Stand; 1980; 46():275-9. PubMed ID: 6245003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparisons of poliovirus antigen measurements in vitro and in small animals.
    von Seefried A; Bryce E; Campbell JB; Chun JH; Laurence GD; Scollard N; Tsai KS
    Dev Biol Stand; 1981; 47():91-100. PubMed ID: 6262165
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental study on the adsorption of poliomyelitis-vaccination virus type 2, during filtration through millipore-membrane filters].
    Hechmat A
    Zentralbl Bakteriol Orig A; 1972 Apr; 219(4):420-5. PubMed ID: 4145475
    [No Abstract]   [Full Text] [Related]  

  • 34. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
    Samoilovich E; Roivainen M; Titov LP; Hovi T
    J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of inactivated poliovirus vaccine derived from Sabin strains.
    Simizu B; Abe S; Yamamoto H; Tano Y; Ota Y; Miyazawa M; Horie H; Satoh K; Wakabayashi K
    Biologicals; 2006 Jun; 34(2):151-4. PubMed ID: 16679028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal and systemic immunity against poliovirus in mice transgenic for the poliovirus receptor: the poliovirus receptor is necessary for a virus-specific mucosal IgA response.
    Buisman AM; Sonsma JA; Kimman TG; Koopmans MP
    J Infect Dis; 2000 Mar; 181(3):815-23. PubMed ID: 10720499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.
    Wood DJ; Heath AB; Kersten GF; Hazendonk T; Lantinga M; Beuvery EC
    Biologicals; 1997 Mar; 25(1):59-64. PubMed ID: 9167009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic.
    Schaap GJ; Bijkerk H; Coutinho RA; Kapsenberg JG; van Wezel AL
    Prog Med Virol; 1984; 29():124-40. PubMed ID: 6322230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.